These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24652507)

  • 21. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.
    Garnacho-Montero J; Garcia-Garmendia JL; Barrero-Almodovar A; Jimenez-Jimenez FJ; Perez-Paredes C; Ortiz-Leyba C
    Crit Care Med; 2003 Dec; 31(12):2742-51. PubMed ID: 14668610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit.
    Raymond DP; Pelletier SJ; Crabtree TD; Gleason TG; Hamm LL; Pruett TL; Sawyer RG
    Crit Care Med; 2001 Jun; 29(6):1101-8. PubMed ID: 11395583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?
    Kollef MH
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S82-8. PubMed ID: 16894520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
    Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome.
    Magira EE; Islam S; Niederman MS
    Med Intensiva (Engl Ed); 2018 May; 42(4):225-234. PubMed ID: 29033075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.
    Campion M; Scully G
    J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study.
    Garnacho-Montero J; Ortiz-Leyba C; Herrera-Melero I; Aldabó-Pallás T; Cayuela-Dominguez A; Marquez-Vacaro JA; Carbajal-Guerrero J; Garcia-Garmendia JL
    J Antimicrob Chemother; 2008 Feb; 61(2):436-41. PubMed ID: 18056733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.
    Vincent JL; Bihari DJ; Suter PM; Bruining HA; White J; Nicolas-Chanoin MH; Wolff M; Spencer RC; Hemmer M
    JAMA; 1995 Aug 23-30; 274(8):639-44. PubMed ID: 7637145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservative initiation of antimicrobial treatment in ICU patients with suspected ICU-acquired infection: more haste less speed.
    Hranjec T; Sawyer RG
    Curr Opin Crit Care; 2013 Oct; 19(5):461-4. PubMed ID: 23995121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of bloodstream infections in ICUs.
    Timsit JF; Soubirou JF; Voiriot G; Chemam S; Neuville M; Mourvillier B; Sonneville R; Mariotte E; Bouadma L; Wolff M
    BMC Infect Dis; 2014 Nov; 14():489. PubMed ID: 25431091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial.
    Daneman N; Rishu AH; Pinto R; Aslanian P; Bagshaw SM; Carignan A; Charbonney E; Coburn B; Cook DJ; Detsky ME; Dodek P; Hall R; Kumar A; Lamontagne F; Lauzier F; Marshall JC; Martin CM; McIntyre L; Muscedere J; Reynolds S; Sligl W; Stelfox HT; Wilcox ME; Fowler RA;
    Trials; 2018 Feb; 19(1):111. PubMed ID: 29452598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
    Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
    Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients.
    Balandin B; Ballesteros D; Ruiz de Luna R; López-Vergara L; Pintado V; Sancho-González M; Soriano-Cuesta C; Pérez-Pedrero MJ; Asensio-Martín MJ; Fernández-Simón I; Rodríguez-Serrano D; Silva A; Chicot M; Iranzo R; Martínez-Sagasti F; Royuela A
    Int J Antimicrob Agents; 2021 Mar; 57(3):106270. PubMed ID: 33347991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
    Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
    J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinico-microbiological profile and outcomes of nosocomial sepsis in an Indian tertiary care hospital--a prospective cohort study.
    Saravu K; Prasad M; Eshwara VK; Mukhopadhyay C
    Pathog Glob Health; 2015 Jul; 109(5):228-35. PubMed ID: 26184918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
    Wei HJ; Liu LL; Xiaoli LY; Wang YP; Huang D; Pian HY; Zhu YC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.
    Adrie C; Garrouste-Orgeas M; Ibn Essaied W; Schwebel C; Darmon M; Mourvillier B; Ruckly S; Dumenil AS; Kallel H; Argaud L; Marcotte G; Barbier F; Laurent V; Goldgran-Toledano D; Clec'h C; Azoulay E; Souweine B; Timsit JF;
    J Infect; 2017 Feb; 74(2):131-141. PubMed ID: 27838521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal nosocomial sepsis in a level-III NICU: evaluation of the causative agents and antimicrobial susceptibilities.
    Yalaz M; Cetin H; Akisu M; Aydemir S; Tunger A; Kültürsay N
    Turk J Pediatr; 2006; 48(1):13-8. PubMed ID: 16562780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empiric Antibiotic Therapy of Nosocomial Bacterial Infections.
    Reddy P
    Am J Ther; 2016; 23(4):e982-94. PubMed ID: 24413366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.